A Transplant or Cancer Resilience Intervention
A Resilience Intervention Involving Mindfulness Training for Transplant and Cancer Patients and Their Caregivers
1 other identifier
interventional
60
1 country
1
Brief Summary
The overall aim of this protocol is to examine patient and care-giver outcomes and acceptance of a new 6 week intervention in Arizona for our transplant and cancer patients and their care-givers, designed to improve quality of life, decrease perceived stress, and improve medical outcomes, that has been approved as a pilot clinical program at Mayo Clinic in Arizona.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2012
CompletedFirst Posted
Study publicly available on registry
June 27, 2012
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2014
CompletedOctober 7, 2014
October 1, 2014
1.7 years
June 21, 2012
October 6, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient questionaire
baseline to 6 weeks
Study Arms (1)
Participant in MBRT
ACTIVE COMPARATOR6 sessions of Mindfulness Based Resilience Training
Interventions
Eligibility Criteria
You may qualify if:
- Patient listed for liver, heart, kidney, or bone marrow transplant
- Patient who has received a liver, heart, kidney, or bone marrow transplant
- Caregiver of transplant patient
- patient with diagnosis of cancer, either active or in remission
- supportive care partner of cancer patient
You may not qualify if:
- Suicidal
- Severe cognitive impairment
- psychotic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Stonnington, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair, Department of Psychiatry & Psychology
Study Record Dates
First Submitted
June 21, 2012
First Posted
June 27, 2012
Study Start
September 1, 2012
Primary Completion
May 1, 2014
Study Completion
May 1, 2014
Last Updated
October 7, 2014
Record last verified: 2014-10